Studies have highlighted that SIRT6 mitigates AKI by inhibiting the Amyloid β-Composite Proteinase, Secondary Structure Domain (ACMSD) signaling pathway, enhancing lipid metabolism, and reducing apoptosis in renal tubular epithelial cells [89]. Here, SIRT6 is linked to acute kidney injury.